Initiator Pharma A/S
STO:INIT
Income Statement
Earnings Waterfall
Initiator Pharma A/S
Income Statement
Initiator Pharma A/S
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(23)
|
(36)
|
(45)
|
(43)
|
(42)
|
(35)
|
(31)
|
(29)
|
(27)
|
(22)
|
(18)
|
(16)
|
(15)
|
(14)
|
(12)
|
(14)
|
|
| Selling, General & Administrative |
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(22)
|
(35)
|
(43)
|
(40)
|
(38)
|
(32)
|
(27)
|
(26)
|
(23)
|
(18)
|
(14)
|
(12)
|
(11)
|
(10)
|
(9)
|
(11)
|
|
| Operating Income |
(23)
N/A
|
(36)
-58%
|
(45)
-24%
|
(43)
+5%
|
(42)
+2%
|
(35)
+15%
|
(31)
+13%
|
(29)
+5%
|
(27)
+8%
|
(22)
+19%
|
(18)
+18%
|
(16)
+11%
|
(15)
+10%
|
(14)
+6%
|
(12)
+8%
|
(14)
-9%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
1
|
1
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(1)
|
(1)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(24)
N/A
|
(38)
-55%
|
(46)
-22%
|
(43)
+5%
|
(44)
-2%
|
(38)
+13%
|
(35)
+8%
|
(33)
+6%
|
(28)
+16%
|
(23)
+19%
|
(17)
+25%
|
(15)
+9%
|
(15)
+4%
|
(13)
+10%
|
(12)
+7%
|
(14)
-9%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
3
|
3
|
3
|
3
|
6
|
6
|
6
|
6
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
|
| Income from Continuing Operations |
(21)
|
(34)
|
(43)
|
(40)
|
(38)
|
(33)
|
(29)
|
(27)
|
(28)
|
(23)
|
(17)
|
(15)
|
(13)
|
(11)
|
(11)
|
(12)
|
|
| Net Income (Common) |
(21)
N/A
|
(34)
-63%
|
(43)
-24%
|
(40)
+6%
|
(38)
+4%
|
(33)
+15%
|
(29)
+10%
|
(27)
+7%
|
(28)
-2%
|
(23)
+19%
|
(17)
+25%
|
(15)
+9%
|
(13)
+16%
|
(11)
+11%
|
(11)
+8%
|
(12)
-10%
|
|
| EPS (Diluted) |
-0.48
N/A
|
-0.78
-63%
|
-0.81
-4%
|
-0.77
+5%
|
-0.8
-4%
|
-0.62
+23%
|
-0.51
+18%
|
-0.53
-4%
|
-0.53
N/A
|
-0.41
+23%
|
-0.3
+27%
|
-0.28
+7%
|
-0.23
+18%
|
-0.2
+13%
|
-0.19
+5%
|
-0.16
+16%
|
|